Global Cell And Gene Therapy Manufacturing Market By Therapy Type (Cell therapy, Gene therapy) By Mode (In-house Manufacturing, Contract Manufacturing (CDMOs & CMOs)) By Scale (Preclinical and Clinical-Scale, Commercial-Scale) By Application (Oncology (Cancer Treatment), Neurological Disorders, Cardiovascular Diseases, Rare & Genetic Disorders, Infectious Diseases, Musculoskeletal Disorders, Autoimmune Diseases, Other Applications) By End-user (Pharmaceutical & Biotechnology Companies, Contract Development & Manufacturing Organizations (CDMOs/CMOs), Research Institutes & Academic Organizations, Hospitals & Clinics) By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends, and Forecast 2025-2034
- Published date: April 2025
- Report ID: 146488
- Number of Pages: 394
- Format:
-
-
-
- Lonza Group AG Company Profile
- Bluebird Bio Inc.
- Catalent Inc.
- F. Hoffmann-La Roche Ltd.
- Samsung Biologics
- Boehringer Ingelheim
- Cellular Therapeutics
- Hitachi Chemical Co., Ltd.
- Takara Bio Inc.
- Miltenyi Biotec
- Thermo Fisher Scientific Company Profile
- F. Hoffmann-La Roche Ltd
- Novartis AG Company Profile
- Merck KGaA Company Profile
- Others
- settingsSettings
Our Clients
✖
Request a Sample Report
We'll get back to you as quickly as possible
Single User
$6,000
$3,999
USD / per unit
save 24%
|
Multi User
$8,000
$5,999
USD / per unit
save 28%
|
Corporate User
$10,000
$6,999
USD / per unit
save 32%
|
|
---|---|---|---|
e-Access | |||
Report Library Access | |||
Data Set (Excel) | |||
Company Profile Library Access | |||
Interactive Dashboard | |||
Free Custumization | No | up to 10 hrs work | up to 30 hrs work |
Accessibility | 1 User | 2-5 User | Unlimited |
Analyst Support | up to 20 hrs | up to 40 hrs | up to 50 hrs |
Benefit | Up to 20% off on next purchase | Up to 25% off on next purchase | Up to 30% off on next purchase |
Buy Now ($ 3,999) | Buy Now ($ 5,999) | Buy Now ($ 6,999) |